Mayne Pharma Group Ltd.

Mayne Pharma Group Ltd.

Mayne Pharma Group Ltd.

Overview
Date Founded

2005

Headquarters

1528 Main North Road,Salisbury South,Salisbury, South Australia (SA) 5106

Type of Company

Public

Employees (Worldwide)

1,000

Industries

Pharmaceuticals

Company Description

Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. It operates through the following segments: Generic Products, Specialty Brands, Metrics Contract Services, and Mayne Pharma International. The Generic Products segment involves in the manufacture and distribution of generic and branded pharmaceutical products. The Metrics Contract Services segment provides contract pharmaceutical services. The Specialty brands segments includes the distribution of branded pharmaceutical products. The Mayne Pharma International segment offers manufacturing and selling of branded and generic pharmaceutical products and provides contract manufacturing services to third party customers within Australia. The company was founded in 1845 and is headquartered in Salisbury, Australia.

Website

http://www.maynepharma.com

Contact Data
Trying to get in touch with decision makers at Mayne Pharma Group Ltd.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
In The News
Targeted News Service
December 10, 2020
Mayne Pharma Assigned Patent for Halobetasol Foam Composition, Method of Use Thereof
Business Wire
November 24, 2020
Global Antibiotics Market to Grow by $4.44 Billion During 2020-2024 | Rising Prevalence of Infectious Diseases to Boost Growth | Technavio
ENP Newswire
October 7, 2020
-Mithra Announces FDA update
RelSci
October 1, 2020
Peter Paltoglou is now serving in a new position at Mayne Pharma Group Ltd.
ENP Newswire
September 30, 2020
-Mayne Pharma Appoints Chief Financial Officer

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
Executives & Employees
See More
Scott Richards

Chief Executive Officer, MD & Executive Director

Peter Paltoglou

Chief Financial Officer

Stefan J. Cross

President-International Operations

Richard Moldin

President, Generics Products Division

Stefan Lukas

Director-Product Development

Brant Schofield

Executive Vice President, Specialty Brands

Leigh Willis

Vice President, Quality

Kate Rintoul

Executive Vice President & General Counsel

Laura Loftus

Secretary & Associate General Counsel

Andrew Herdman

Vice President-Group Human Resources

Board of Directors
Roger Corbett

Member of the Dean's Advisory Group at The University of Sydney

Patrick Blake

Director at Sutter Health

Bruce L. Mathieson

Director at Australian Leisure & Hospitality Group Ltd.

Scott Richards

Chief Executive Officer, MD & Executive Director at Mayne Pharma Group Ltd.

Nancy Dolan

Partner at PricewaterhouseCoopers LLP

Bruce Robinson

Former Dean at University of Sydney - Sydney Medical School

Frank C. Condella, Jr.

Former Chief Executive Officer at Juniper Pharmaceuticals, Inc.

Ian Frank Scholes

Trending People
Miami Dolphins
Marcus Hayes: Eagles should pursue Alex Smith when Washington cuts him - The Miami Herald
The European Medicines Agency
ChemoCentryx Inc (CCXI) Q4 2020 Earnings Call Transcript - Nasdaq
Democratic Party
Bernie Sanders promises Senate vote on $15 minimum wage as Democrats get ready t... - Business Insider
US Securities & Exchange Commission
Preferred Apartment Communities, Inc. Reports Results for Fourth Quarter 2020 - Nasdaq
RBC Capital Markets LLC
Agile Therapeutics (AGRX) Q4 2020 Earnings Call Transcript - Nasdaq
Trending Organizations
Miami Dolphins
Marcus Hayes: Eagles should pursue Alex Smith when Washington cuts him - The Miami Herald
The European Medicines Agency
ChemoCentryx Inc (CCXI) Q4 2020 Earnings Call Transcript - Nasdaq
Democratic Party
Bernie Sanders promises Senate vote on $15 minimum wage as Democrats get ready t... - Business Insider
US Securities & Exchange Commission
Preferred Apartment Communities, Inc. Reports Results for Fourth Quarter 2020 - Nasdaq
RBC Capital Markets LLC
Agile Therapeutics (AGRX) Q4 2020 Earnings Call Transcript - Nasdaq
Paths to Mayne Pharma Group Ltd.
Potential Connections via
Relationship Science
You
Mayne Pharma Group Ltd.
Owners & Shareholders
Details Hidden
Investors Mutual Ltd.

IML has a conservative investment style with a long-term focus and aims to deliver consistent returns for clients. The firm employs a fundamental, quality & value-based approach to investing. They utilize active, bottom-up approach to identifying, researching and valuing companies. Their approach is systematic, disciplined and focuses on finding companies that meet their investment quality criteria and then determining an appropriate valuation for those companies.

Details Hidden
Investors Mutual Ltd.

IML has a conservative investment style with a long-term focus and aims to deliver consistent returns for clients. The firm employs a fundamental, quality & value-based approach to investing. They utilize active, bottom-up approach to identifying, researching and valuing companies. Their approach is systematic, disciplined and focuses on finding companies that meet their investment quality criteria and then determining an appropriate valuation for those companies.

Recent Transactions
Details Hidden

Mayne Pharma Group Ltd. purchases Spear Pharmaceuticals, Inc. /Generic Efudex Operations from Bausch Health Cos., Inc.

Details Hidden

Mayne Pharma Group Ltd. purchases Teva Pharmaceutical Industries Ltd. /Generic Products Portf from Teva Pharmaceutical Industries Ltd.

Details Hidden

Mayne Pharma Group Ltd. purchases Forest Laboratories LLC /Esgic Esgic Plus Lorcet Lorcet Plus from Allergan Plc

Transaction Advisors
Legal Advisor
Miller & Martin PLLC

Advised onMayne Pharma Group Ltd. purchases Mayne Pharma, Inc.

Legal Advisor
MinterEllison

Advised onMayne Pharma Group Ltd. purchases Mayne Pharma, Inc.

Legal Advisor
Ashley A. Halfman

Advised onMayne Pharma Group Ltd. purchases Mayne Pharma, Inc.

Legal Advisor
Bruce C. McCall

Advised onMayne Pharma Group Ltd. purchases Mayne Pharma, Inc.

Legal Advisor
Charles W. Forlidas

Advised onMayne Pharma Group Ltd. purchases Mayne Pharma, Inc.

Advisors & Consultants
Advisor
Nick Freeman

Chief Financial Officer at NIB Holdings Ltd.

Legal Advisor
Damian Grave

Partner at Herbert Smith Freehills LLP
Clients
X4 Pharmaceuticals, Inc.

X4 Pharmaceuticals, Inc. operates as a biotechnology company, which engages in developing human antibodies for treating infectious diseases. The company focuses on restoring healthy immune system function by developing novel therapeutics for the treatment of rare diseases. Its products in pipeline include X4P-001, X4P-002, and X4P-003. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan and is headquartered in Cambridge, MA.

Boryung Pharmaceutical Co., Ltd.

Boryung Pharmaceutical Co., Ltd. engages in the manufacture of of drug products. Its main products include Kanarb, Dukarb, Tuvero, TODULA, BESTO, and gelfosM. Its products include cardiovascular, antibiotics, anticancer, amino acid, cosmetics, gastrointestinal, and API. The company was founded on November 11, 1963 and is headquartered in Seoul, South Korea.

Exea Corp.

Exea Corp. is a private company headquartered in Spain that operates in several countries. The firm operates as a holding company with interests in manufactures and distributes perfumery, cosmetics and personal care products.
Key Stats and Financials As of 2020
Market Capitalization
$434M
Total Enterprise Value
$588M
Earnings Per Share
$-0.04
Enterprise Value / Sales
1.87x
TEVNet Income
-9.2x
Debt TEV
0.47x
EBITDAMargin
15.85%
Enterprise Value EBITDAOperating
11.78x
Three Year Compounded Annual Growth Rate Of Revenue
-7.24%
Revenue
$315M
Total Debt
$274M
Total Equity
$718M
Net Profit
$-63.9M
EBITDA
$49.9M
Suppliers
Corium International, Inc. Holding Companies | Menlo Park, California

Corium International, Inc. is a pharmaceutical company. It offers products such as corplex donepezil and memantine. The company was founded by Gary W. Cleary and Adrian L. Faasse, Jr. in 1999 and is headquartered in Menlo Park, CA.

Mithra Pharmaceuticals SA Wholesale: Consumer Non-Durables/Sundries | Liege, Bel

Mithra Pharmaceuticals SA is a belgian biotech company, which engages in the development, manufacture, and commercialization of proprietary and differentiated drugs and generic products dedicated to female healthcare. Mithra also develops and manufactures complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers. The company was founded by Jean-Michel Foidart and François Fornieri on July 8, 1999 and is headquartered in Liege, Belgium.

Douglas Pharmaceuticals Ltd. Pharmaceuticals | Auckland, New Zealand

Douglas Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products include acitretin capsules, anastrozole tablets, Azathioprine film-coated tablets, Clozapine tablets, Dutasteride, Quetiapinetablets and Rivastigmine capsules. The company was founded by Graeme Bruce Douglas in 1967 and is headquartered in Auckland, New Zealand.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Mayne Pharma Group Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Mayne Pharma Group Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Mayne Pharma Group Ltd..